Key result
Poloxamer 407 is comparable to Triton WR-1339 in determining hepatic triglyceride production in mice, but without the unwanted side effects of Triton.
Answers are grounded in this paper and cite their sources.
Supports Poloxamer 407 as alternative in murine models; leaves open human translation for hepatic triglyceride assessment.
Triglyceride (TG), a water-insoluble energy-rich lipid, is secreted by the liver as part of very low density lipoproteins (VLDLs) to supply energy to extrahepatic tissues. Overproduction of VLDL is associated with increased risk of cardiovascular heart disease; this has renewed an interest in factors that affect hepatic TG production. The TG production rate is determined by measuring temporal increases in plasma TG under conditions in which TG hydrolysis by lipoprotein lipase (LPL) is inhibited. The nonionic detergent, Triton WR-1339 (Triton), has commonly been used to inhibit LPL for this purpose. Triton, in addition to inhibition of TG hydrolysis, has properties that have the potential to adversely influence lipoprotein metabolism. Another nonionic detergent, poloxamer 407 (P-407), also inhibits LPL. In these studies, we demonstrate that P-407 is comparable to Triton in the determination of TG production but without the unwanted side effects of Triton.
No takes yet. Share an insight, caveat, or question.
Millar et al. (2005) studied this question. Poloxamer 407 (P-407) vs. Triton WR-1339 was evaluated on Hepatic triglyceride production determination. Poloxamer 407 is comparable to Triton WR-1339 in determining hepatic triglyceride production in mice, but without the unwanted side effects of Triton.
Synapse has enriched 10 related papers. Consider them for comparative context: